Notice of Availability for the Record of Decision of the Environmental Impact Statement for the U.S. Food and Drug Administration, Muirkirk Road Campus Master Plan in Laurel, Maryland, 41403-41404 [2023-13438]

Download as PDF Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices has not been disclosed publicly. The development and publication of the Account Access Guidelines, however, prompted the Board to consider the potential benefits of disclosing the names of institutions that have access to accounts and services. The Board proposed for public comment a requirement for Reserve Banks to publish periodically a list of depository institutions with access to accounts and services, including whether each depository institution with access to accounts and services is federally insured and in which Reserve Bank district the depository institution is located. In addition, the Board proposed to have the Reserve Banks publish a list of depository institutions that have, since the prior publication, received access to accounts and services or no longer have access to accounts and services.2 B. Subsequent Amendment to the Federal Reserve Act Subsequent to the publication of the proposal, the James M. Inhofe National Defense Authorization Act for Fiscal Year 2023 amended the Act by adding a new Section 11C. New Section 11C of the Act requires the Board, not later than 180 days after December 23, 2022, to create and ‘‘maintain a public, online and searchable database’’ of entities that have, or that are requesting, account and service access, along with the status of any request for an account and services.3 For each entity that has, or is requesting access to, accounts and services, new Section 11C of the Act also requires the database to indicate if the entity is a federally insured bank or credit union or a non-federally insured depository institution. II. Notice That the Board Will Not Adopt the Proposed Amendments to the Account Access Guidelines The Board has determined that the disclosure requirements in the Act’s ddrumheller on DSK120RN23PROD with NOTICES1 2 The Board proposed that the list of depository institutions that no longer have access to accounts and/or services would include both depository institutions that lost access to accounts and services and those that gave up their access to accounts and services voluntarily. 3 See 12 U.S.C. 248c. The new Section 11C excludes official accountholders from the list of entities published on the database and defines ‘‘Official accountholders’’ as foreign states (as defined in section 25B of the Act), central banks (as defined in section 25B of the Act) other than a commercial bank, public international organizations entitled to enjoy privileged examples and immunities as an international organization under the International Organizations Immunities Act (22 U.S.C. 288 et seq.), and any governmental entity for which the Secretary of Treasury has directed a Reserve Bank to receive deposits as fiscal agent of the United States under section 15 of the Act. VerDate Sep<11>2014 19:33 Jun 23, 2023 Jkt 259001 new Section 11C substantially supplant the Board’s proposal to incorporate a disclosure requirement into the Account Access Guidelines. Therefore, the Board will not adopt its proposed amendments to the Account Access Guidelines. By order of the Board of Governors of the Federal Reserve System. Margaret McCloskey Shanks, Deputy Secretary of the Board. [FR Doc. 2023–13460 Filed 6–23–23; 8:45 am] BILLING CODE P GENERAL SERVICES ADMINISTRATION [Notice–PBS–2023–03; Docket No. 2023– 0002; Sequence No. 20] Notice of Availability for the Record of Decision of the Environmental Impact Statement for the U.S. Food and Drug Administration, Muirkirk Road Campus Master Plan in Laurel, Maryland Public Buildings Service (PBS), National Capital Region, General Services Administration (GSA). ACTION: Notice. AGENCY: GSA issued a Record of Decision (ROD) for the Food and Drug Administration (FDA) Muirkirk Road Campus (MRC) Master Plan, in Laurel, Maryland, on June 16, 2023. The ROD was prepared in accordance with the National Environmental Policy Act (NEPA) of 1969, the Council on Environmental Quality Regulations, and the GSA PBS NEPA Desk Guide. DATES: Applicable: Friday, June 16, 2023. SUMMARY: FOR FURTHER INFORMATION CONTACT: Lindsey Veas, GSA, National Capital Region, PBS, Office of Planning and Design Quality, at 202–262–9236. SUPPLEMENTARY INFORMATION: Background The General Services Administration, in cooperation with the FDA, has prepared a Master Plan for the MRC in Laurel, Maryland. The MRC Master Plan creates a framework to guide development and add capacity over the course of next 10 to 30 years. The FDA owns 249 acres of land at Muirkirk Road. The MRC West Parcel comprises 197 acres west of Odell Road. The remaining 52 acres makes up the MRC East Parcel located east of Odell Road. The FDA acquired the land for the Beltsville Research Facility (BRF) from the U.S. Department of Agriculture (USDA) in 1964. Today, the MRC is home to the Center for Veterinary Medicine (CVM), the Center for Food PO 00000 Frm 00033 Fmt 4703 Sfmt 4703 41403 Safety and Applied Nutrition (CFSAN), and support staff. Previous master plans approved by National Capital Planning Commission (NCPC) and Prince George’s County include the 1966 Site Development Plan and the 1981 Master Plan. The MRC’s current population is 300 employees; the 1966 and 1981 Master Plans limited future population growth to 1,800 employees. The MRC Master Plan evolved throughout the master planning process that began in September 2020. Initially, the Draft Master Plan included two phases of office buildings without any laboratories. The first phase accommodates 700 additional staff, and the second phase 800 additional staff, bringing the total campus population up to 1,800. As a result of the COVID–19 pandemic, the workplace environment has gone through a fundamental change with a higher percentage of people working remotely. The FDA adopted the U.S. Department of Health and Human Services (HHS) 21st Century Workplace Space Planning Policy. Under this policy, a new workplace model based on increased telework provides efficient use of space and significantly reduces rent and rent related costs. Moving forward, HHS’s policy is to provide dedicated workstations and offices only for staff who report to an office six or more days per pay period. Shared workstations and offices will be available for employees who predominantly telework fewer than six days per pay period. Based on current trends in teleworking, FDA’s White Oak campus has significant capacity to absorb future growth and consolidation of FDA employees within the DC metropolitan area from leased space as the leases expire. For laboratory employees, remote work is not possible due to the nature of the work and existing laboratories at FDA’s White Oak Campus are fully occupied. Therefore, FDA shifted its focus for the MRC from mostly new office space to also increasing the amount of laboratory space. The Master Plan provides a framework for development at the MRC to accommodate up to 1,800 FDA employees and support staff. GSA completed an EIS that assessed the impacts of the population increase and additional growth needed on the MRC to support the increased population. Preferred Alternative GSA has chosen to implement Alternative B: Dual Campus, as defined in the Final EIS (GSA, April 2023). This decision is based on analyses contained in the MRC Master Plan Draft EIS issued E:\FR\FM\26JNN1.SGM 26JNN1 ddrumheller on DSK120RN23PROD with NOTICES1 41404 Federal Register / Vol. 88, No. 121 / Monday, June 26, 2023 / Notices in December 2020, the MRC Master Plan Final EIS issued in April 2023, and the comments of Federal and State agencies, stakeholder organizations, members of the public and elected officials and other information in the Administrative Record. Implementation of Alternative B will be distributed between the MOD 1 and MOD 2 buildings and the Beltsville Research Facility (BRF) site. Alternative B has been broken out into three phases which include: • Phase 1—construction of an approximate 18,000-square-foot annex to the MOD 2 building. The population at the MRC West Parcel will remain at 300. The annex building will accommodate both staff from the BRF and the renovation occurring within MOD 2. • Phase 2—construction of two laboratory buildings that will accommodate 168 scientists and support staff in approximately 168,000 gross square feet (gsf) of lab space and 6,300 gsf of special use space. Phase 2 includes the removal of the surface parking lot adjacent to MOD 1 and the construction of a parking garage with 235 spaces. An approximate 10,000 gsf maintenance/storage building adjacent to the new parking garage will also be built. Phase 2 will include maintaining the metal warehouse building and fitness center at the BRF, creating a temporary surface lot on the BRF site, and constructing a new entrance to Odell Road for truck screening. A visitor parking lot will be constructed and the Muirkirk Road entrance will be rebuilt with a shared drop-off. • Phase 3—construction of two office buildings that will accommodate a population of 1,332 and shared use space to support the campus. The two new office buildings will be constructed on the site of the BRF. The total gross area is approximately 166,500 gsf of office space and 24,5000 gsf of special use space. This phase will also include a four-level parking garage for 665 spaces. Additionally, during Phase 3, temporary parking and all remaining existing buildings at the BRF site will be removed. An elevated boardwalk will be constructed within the natural landscape that will connect the laboratory buildings with the office buildings. A skybridge between the laboratory and office buildings will encourage collaboration. Alternative B will also include space for shared amenities including a conference center, cafeteria, and fitness center. Alternative B is necessary to continue to guide future long-term development of the MRC. Alternative B highlights VerDate Sep<11>2014 19:33 Jun 23, 2023 Jkt 259001 views, improves connectivity and walkability, and conserves the natural landscape. Alternative B is in line with the Master Plan as both aim to: • maintain a 100-foot landscape buffer along the perimeter of the campus, • set the buildings back at least 75 feet from the interior roadways, • respect the woodlands as much as possible and make them accessible for employees, • create new view corridors into the woodlands at the heart of the campus, • avoid development and human interference in the pasture areas as these are being used by FDA for research and the preservation of open space, • connect the existing and Phase 2 buildings through a continuous service corridor, • allow people to move between new buildings through a physical connection that protects them from the elements, and • conserve the stream valleys and natural drainage patterns collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by August 25, 2023. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Location of Record of Decision Submission’’ or ‘‘More Search Options’’ The ROD can be found on GSA’s to find the information collection project website at www.gsa.gov/ncrnepa. document(s) that are accepting comments. Mydelle Wright, 2. By regular mail. You may mail Director, Office of Planning and Design written comments to the following Quality, Public Buildings Service, National address: CMS, Office of Strategic Capital Region, General Services Operations and Regulatory Affairs, Administration. Division of Regulations Development, [FR Doc. 2023–13438 Filed 6–23–23; 8:45 am] Attention: Document Identifier/OMB BILLING CODE 6820–34–P Control Number:lll, Room C4–26– 05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. DEPARTMENT OF HEALTH AND To obtain copies of a supporting HUMAN SERVICES statement and any related forms for the proposed collection(s) summarized in Centers for Medicare & Medicaid this notice, please access the CMS PRA Services website by copying and pasting the [Document Identifier: CMS–10861 and CMS– following web address into your web 10137] browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ Agency Information Collection PaperworkReductionActof1995/PRAActivities: Proposed Collection; Listing. Comment Request FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. AGENCY: Centers for Medicare & Medicaid Services, Health and Human SUPPLEMENTARY INFORMATION: Services (HHS). Contents ACTION: Notice. This notice sets out a summary of the use and burden associated with the SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is announcing following information collections. More detailed information can be found in an opportunity for the public to each collection’s supporting statement comment on CMS’ intention to collect and associated materials (see information from the public. Under the ADDRESSES). Paperwork Reduction Act of 1995 (the PRA), federal agencies are required to CMS–10861—Health Insurance publish notice in the Federal Register Common Claims Form concerning each proposed collection of CMS–10137—Solicitation for information (including each proposed Applications for Medicare extension or reinstatement of an existing prescription Drug Plan 2025 Contracts PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\26JNN1.SGM 26JNN1

Agencies

[Federal Register Volume 88, Number 121 (Monday, June 26, 2023)]
[Notices]
[Pages 41403-41404]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-13438]


=======================================================================
-----------------------------------------------------------------------

GENERAL SERVICES ADMINISTRATION

[Notice-PBS-2023-03; Docket No. 2023-0002; Sequence No. 20]


Notice of Availability for the Record of Decision of the 
Environmental Impact Statement for the U.S. Food and Drug 
Administration, Muirkirk Road Campus Master Plan in Laurel, Maryland

AGENCY: Public Buildings Service (PBS), National Capital Region, 
General Services Administration (GSA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: GSA issued a Record of Decision (ROD) for the Food and Drug 
Administration (FDA) Muirkirk Road Campus (MRC) Master Plan, in Laurel, 
Maryland, on June 16, 2023. The ROD was prepared in accordance with the 
National Environmental Policy Act (NEPA) of 1969, the Council on 
Environmental Quality Regulations, and the GSA PBS NEPA Desk Guide.

DATES: Applicable: Friday, June 16, 2023.

FOR FURTHER INFORMATION CONTACT: Lindsey Veas, GSA, National Capital 
Region, PBS, Office of Planning and Design Quality, at 202-262-9236.

SUPPLEMENTARY INFORMATION:

Background

    The General Services Administration, in cooperation with the FDA, 
has prepared a Master Plan for the MRC in Laurel, Maryland. The MRC 
Master Plan creates a framework to guide development and add capacity 
over the course of next 10 to 30 years. The FDA owns 249 acres of land 
at Muirkirk Road. The MRC West Parcel comprises 197 acres west of Odell 
Road. The remaining 52 acres makes up the MRC East Parcel located east 
of Odell Road. The FDA acquired the land for the Beltsville Research 
Facility (BRF) from the U.S. Department of Agriculture (USDA) in 1964. 
Today, the MRC is home to the Center for Veterinary Medicine (CVM), the 
Center for Food Safety and Applied Nutrition (CFSAN), and support 
staff.
    Previous master plans approved by National Capital Planning 
Commission (NCPC) and Prince George's County include the 1966 Site 
Development Plan and the 1981 Master Plan. The MRC's current population 
is 300 employees; the 1966 and 1981 Master Plans limited future 
population growth to 1,800 employees. The MRC Master Plan evolved 
throughout the master planning process that began in September 2020. 
Initially, the Draft Master Plan included two phases of office 
buildings without any laboratories. The first phase accommodates 700 
additional staff, and the second phase 800 additional staff, bringing 
the total campus population up to 1,800.
    As a result of the COVID-19 pandemic, the workplace environment has 
gone through a fundamental change with a higher percentage of people 
working remotely. The FDA adopted the U.S. Department of Health and 
Human Services (HHS) 21st Century Workplace Space Planning Policy. 
Under this policy, a new workplace model based on increased telework 
provides efficient use of space and significantly reduces rent and rent 
related costs. Moving forward, HHS's policy is to provide dedicated 
workstations and offices only for staff who report to an office six or 
more days per pay period. Shared workstations and offices will be 
available for employees who predominantly telework fewer than six days 
per pay period. Based on current trends in teleworking, FDA's White Oak 
campus has significant capacity to absorb future growth and 
consolidation of FDA employees within the DC metropolitan area from 
leased space as the leases expire. For laboratory employees, remote 
work is not possible due to the nature of the work and existing 
laboratories at FDA's White Oak Campus are fully occupied. Therefore, 
FDA shifted its focus for the MRC from mostly new office space to also 
increasing the amount of laboratory space.
    The Master Plan provides a framework for development at the MRC to 
accommodate up to 1,800 FDA employees and support staff. GSA completed 
an EIS that assessed the impacts of the population increase and 
additional growth needed on the MRC to support the increased 
population.

Preferred Alternative

    GSA has chosen to implement Alternative B: Dual Campus, as defined 
in the Final EIS (GSA, April 2023). This decision is based on analyses 
contained in the MRC Master Plan Draft EIS issued

[[Page 41404]]

in December 2020, the MRC Master Plan Final EIS issued in April 2023, 
and the comments of Federal and State agencies, stakeholder 
organizations, members of the public and elected officials and other 
information in the Administrative Record.
    Implementation of Alternative B will be distributed between the MOD 
1 and MOD 2 buildings and the Beltsville Research Facility (BRF) site. 
Alternative B has been broken out into three phases which include:
     Phase 1--construction of an approximate 18,000-square-foot 
annex to the MOD 2 building. The population at the MRC West Parcel will 
remain at 300. The annex building will accommodate both staff from the 
BRF and the renovation occurring within MOD 2.
     Phase 2--construction of two laboratory buildings that 
will accommodate 168 scientists and support staff in approximately 
168,000 gross square feet (gsf) of lab space and 6,300 gsf of special 
use space. Phase 2 includes the removal of the surface parking lot 
adjacent to MOD 1 and the construction of a parking garage with 235 
spaces. An approximate 10,000 gsf maintenance/storage building adjacent 
to the new parking garage will also be built. Phase 2 will include 
maintaining the metal warehouse building and fitness center at the BRF, 
creating a temporary surface lot on the BRF site, and constructing a 
new entrance to Odell Road for truck screening. A visitor parking lot 
will be constructed and the Muirkirk Road entrance will be rebuilt with 
a shared drop-off.
     Phase 3--construction of two office buildings that will 
accommodate a population of 1,332 and shared use space to support the 
campus. The two new office buildings will be constructed on the site of 
the BRF. The total gross area is approximately 166,500 gsf of office 
space and 24,5000 gsf of special use space. This phase will also 
include a four-level parking garage for 665 spaces. Additionally, 
during Phase 3, temporary parking and all remaining existing buildings 
at the BRF site will be removed.
    An elevated boardwalk will be constructed within the natural 
landscape that will connect the laboratory buildings with the office 
buildings. A skybridge between the laboratory and office buildings will 
encourage collaboration. Alternative B will also include space for 
shared amenities including a conference center, cafeteria, and fitness 
center.
    Alternative B is necessary to continue to guide future long-term 
development of the MRC. Alternative B highlights views, improves 
connectivity and walkability, and conserves the natural landscape. 
Alternative B is in line with the Master Plan as both aim to:
     maintain a 100-foot landscape buffer along the perimeter 
of the campus,
     set the buildings back at least 75 feet from the interior 
roadways,
     respect the woodlands as much as possible and make them 
accessible for employees,
     create new view corridors into the woodlands at the heart 
of the campus,
     avoid development and human interference in the pasture 
areas as these are being used by FDA for research and the preservation 
of open space,
     connect the existing and Phase 2 buildings through a 
continuous service corridor,
     allow people to move between new buildings through a 
physical connection that protects them from the elements, and
     conserve the stream valleys and natural drainage patterns

Location of Record of Decision

    The ROD can be found on GSA's project website at www.gsa.gov/ncrnepa.

Mydelle Wright,
Director, Office of Planning and Design Quality, Public Buildings 
Service, National Capital Region, General Services Administration.
[FR Doc. 2023-13438 Filed 6-23-23; 8:45 am]
BILLING CODE 6820-34-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.